CASI PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
CASI PHARMACEUTICALS, INC. (CASIF) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$27.67 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-05-15
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$27.67M 20-F · filed 2026-05-15 |
| 2024-12-31 | -$32.98M 20-F · filed 2026-05-15 |
| 2023-12-31 | $144.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | -$12.36M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$32.17M 20-F · filed 2024-03-28 |
| 2020-12-31 | -$40.63M 20-F · filed 2023-04-26 |